ChronicleBio builds an AI-ready, multi-omic data platform and biobank for complex chronic and neuroimmune conditions, including POTS, ME/CFS, and Long COVID
ChronicleBio builds an AI-ready, multi-omic data platform and biobank for complex chronic and neuroimmune conditions, including POTS, ME/CFS, and Long COVID. It combines longitudinal patient data, biospecimens, clinical and patient-reported information, and AI models to identify disease mechanisms, stratify patients, discover biomarkers, and develop targeted therapeutics, both independently and with biopharma partners.